Business

Advance Notice Filed with Sernova Corp. for the Nomination of Two Director Nominees

Advance Notice Filed with Sernova Corp. for the Nomination of Two Director Nominees Can...

articleSernova Biotherapeutics IncMarch 22, 20235/company/sernova-corp/news/advance-notice-filed-with-sernova-corp-for-the-nomination-of-two-director-nominees
Advance Notice Filed with Sernova Corp. for the Nomination of Two Director Nominees

About this update from Sernova Biotherapeutics Inc

[{"type":"text","content":"\n \n \n \n Advance Notice Filed with Sernova Corp. for the Nomination of Two Director Nominees\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prngen3{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n \n ,\n \n \n March 22, 2023\n \n \n /CNW/ -\n \n Betty Anne Millar\n \n has filed a notice (the \"Notice\") with Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (\"Sernova\" or the \"Company\") for the nomination of two highly experienced independent directors to be elected to the board of Sernova at the annual general meeting to be held on\n \n April 27, 2023\n \n (the \"Meeting\"). Mrs. Millar, together with joint actors (the \"Group of Shareholders\"), holds directly and indirectly an aggregate of 35,789,615 shares, representing approximately 12% of the Company's issued and outstanding common shares of Sernova,\n \n \n \n \n \n \n \n \n \n Mrs. Millar's proposed slate of director nominees are Dr. Steven Sangha and Mr. Bertram von Plettenberg (the \"Nominees\"). Mrs. Millar has filed the Notice in accordance with the Company's advance notice by-law (By- Law No. 3). Mrs. Millar held 4.35 million common shares in Sernova as of the Meeting's record date, March 8, 2023. A copy of the Notice is attached.\n \n \n The Group of Shareholders consists of joint actors Mrs. Millar, Dr.\n \n Steven Sangha\n \n , Mr. von Plettenberg, Stephan Dubreuil, Tomas Angel, and Garry Deol.\n \n \n The Group of Shareholders has been in discussions with the current CEO and Chairman of Sernova to communicate their desire to have Nominees on the circ...

More updates from Sernova Biotherapeutics Inc